Top Products for Top Results in Hong Kong This October

HONG KONG, Oct. 15, 2012 /PRNewswire/ — MEGA SHOW PART 1 is the most important sourcing show in Hong Kong this month with over 5,025 booths of export-ready Asian suppliers presenting the very best and newest in gifts, housewares, toys, premiums, stationery, glassware trends, gift wrap and packaging and festive products to over 52,000 buyers. MEGA SHOW PART 1 is open from Saturday 20 to Tuesday 23 OCTOBER and the trade only show will take place at the downtown Hong Kong Convention and Exhibition Centre, 1 Expo Drive, Wanchai, Hong Kong.

MEGA SHOW PART 1 will present 7 major products sectors, GIFTS, HOUSEWARES AND HOME DECOR, CHRISTMAS, FESTIVE AND SEASONAL, TOYS AND GAMES plus BABY AND CHILD, GIFTWRAP AND PACKAGING, GLASSWARE TRENDS and ASIA AND INTERNATIONAL FOCUS presenting a diverse selection of GIFTS AND HOMEWARES, plus the nine group pavilions from MAINLAND CHINA, JAPAN, SOUTH KOREA, INDIA, INDONESIA, TAIWAN, THAILAND, THE PHILIPPINES and VIETNAM.

Products from 32 countries and region will be on display from Australia, Bangladesh, Belgium, Canada, Czech Republic, Finland, Mainland China, France, Germany, Hong Kong, India, Indonesia, Israel, Italy, Japan, South Korea, Malaysia, Nepal, New Zealand, Pakistan, The Philippines, Saudi Arabia, Singapore, South Africa, Spain, Taiwan, Thailand, Turkey, U.A.E, U.K., U.S.A. and Vietnam.

Designers and manufacturers in Asia are now also contributing to the importance of sustainability by including GO GREEN products across all sectors of consumer retail goods. Over 650companies this year will be presenting eco-friendly products under the expanding GO GREEN campaign.

The clearly-defined product and country of origin sectors that have been part of the shows for the past two years have been further enhanced to ensure locating the suppliers during the show days is effective for both buyers and sellers. Two VIP buyer lounges, ample refreshment areas, wi-fi access, travel and accommodation assistance, business centre, and an exhibitor locator system all are available throughout the show.

MEGA SHOW PART 1 is a proven major buying and selling platform, bringing together the key global sourcing players in one place – Hong Kong, at one time-every October, and is acknowledged, after its twenty-one year history, as the key trade show with the most comprehensive selection of well-priced products, designed and produced in Asia and sold world-wide.

MEGA SHOW PART 1 and 2, managed by Kenfair, are UFI Approved Events.

Website: http://www.mega-show.com

14th West Lake International Expo in Hangzhou, China Opens

HANGZHOU, China /PRNewswire/ — The 14th West Lake International Expo Hangzhou, China officially opened on October 13. Themed “Quality West Lake Expo, Happy Hangzhou”, the 22-day event features 132 programs and 14 sub-venues with exhibitors from more than 40 countries. The expo is expected to receive as many as 10 million visitors and generate 10 billion yuan (approx. $US 1.6 billion) in trade business, US$1 billion in contracted foreign investment and 10 billion yuan (approx. $US 1.6 billion) in domestic investment.
This year’s expo brings in 38 new programs, highlighting the importance of the role that the expo will play in the economic development of Hangzhou. More than two-thirds of the programs are closely related to industrial transformation, including the International Investment Cooperation Conference, the China-Latin America Entrepreneur Summit, the Hangzhou Cultural and Creative Industry Expo, the China 100-CEO Communication Conference, the Hangzhou Electronic Information Expo, the New Energy Vehicle Industry Expo and the Global Lighting Conference. The expo’s floor space of 100,000 square meters, of which 20 percent has been taken by international booths, is attracting more than 50,000 professional visitors including 5,000 from outside of China. In numbers, exhibits by foreign companies account for more than 55 percent of the total. A series of internationally recognized brand events are being held to catch the attention of potential customers, bring together a variety of resources and facilitate economic development.
For more information, please visit http://en.xh-expo.com/index.html.
Source: Hangzhou West Lake Expo Organizing Committee

Nopras Technologies Announces Schedule of Events at 2012 AAPS Annual Meeting and Exposition

NOVI, Mich. /PRNewswire/ — Nopras Technologies Inc. (www.nopras-tech.com), a global management consulting firm to the pharmaceutical, biologics/biotechnology and medical device industries, has announced an event at the 2012 annual meeting and exposition of the American Association of Pharmaceutical Scientists (AAPS) in Chicago, IL.
“Nopras Technologies’ business model has changed significantly over the last few years as we have expanded our services globally,” said Lori Przybylo, Senior Account Manager of Nopras Technologies. “Many of our clients are interested in that evolution and we’re eager to talk with them about what it means in terms of these opportunities.”
“But we also want to emphasize the things that haven’t changed: our focus is still on delivering quality, regulatory and compliance solutions that have made us a leading global player in the life sciences industry. Examples of that work are what we are sharing at AAPS this year.”
Integrating technical, process, organizational, and business skills, Nopras Technologies industry experts enable life sciences companies to achieve optimal compliance and quality performance, operational excellence, and greater business value from their operations.
“We know the different challenges our clients face, the cultures in which they operate, and the unique demands that come with that,” stated Ms. Przybylo. “We don’t require a long, steep learning curve, and you will find that we bring a keen understanding, fresh perspectives and strategic abilities to the table from the ‘get go.'”
Nopras Technologies will be at Booth 2452 in the convention center exhibit hall, where it will host its traditional “Booth Bar” happy hour from 4:00 to 5:30 PM on Monday, October 15.
“I’m very proud of what we are sharing at AAPS,” said Lori Przybylo. “It shows the high-caliber work that any client can expect from Nopras Technologies.”
About Nopras Technologies, Inc.
Nopras Technologies has worked with clients globally in creating value to solve most difficult technical, quality, regulatory and compliance problems to advance new and existing medicines that improve human health. This success is based on our consultants’ abilities to provide industry expertise covering a wide range of technical disciplines, grown from a solid base of scientific and engineering fundamental understanding.
The company provides a broad spectrum of Regulatory, Compliance and Quality Services, Operational Improvement and Technical Services, Turnkey Solutions Services (Facility Start-Up and New Product Launch).
Its service portfolio covers FDA and foreign regulations/ guidelines and spans the full product development life cycle; from clinical development through market scrutiny.
The firm’s staff consists of well-credentialed physicians, scientists, engineers, and technical experts from industry leaders with extensive business and industry experience; many of whom are key opinion leaders, have held key management positions and have earned advanced degrees in medicine, science, engineering and business operate as a working team to integrate the different skill sets they offer.
Nopras Technologies assists clients’ advance promising drug candidates from conception through commercialization by providing technical, quality and regulatory support, assisting in process development and optimization, and manufacturing clinical-trial quantities of drug candidates and regulatory submissions.
The company is based in Novi, MI with offices in Fort Washington, PA, Shanghai, China and Singapore. For more information, visit http://www.nopras-tech.com.
Source: Nopras Technologies, Inc.

A New Post Hoc Analysis Indicates asenapine has Effect on Both Manic and Depressive S

ECNP, VIENNA /PRNewswire/ —
Post hoc analyses presented at the 25th European College of Neuropsychopharmacology (ECNP) congress show asenapine achieves significant control of mixed episodes in bipolar I disorder compared to placebo.
– For media outside China, Japan, UK, USA only.
Lundbeck today announced results from post hoc analyses in bipolar I disorder patients experiencing mixed episodes, which found asenapine has a significant effect on both manic and depressive symptoms versus placebo. The analyses used pooled data from two identically designed 3-week, randomised, double-blind flexible dose, placebo- and olanzapine-controlled trials and a 9-week, double-blind olanzapine-controlled extension study.
“One of the most challenging treatment goals in bipolar I disorder is to address mixed episodes, where both manic and depressive symptoms are present,” said Professor Jean-Michel Azorin, Professor of Psychiatry at the Mediterranean University School of Medicine. “Mixed episodes are experienced by more than 40% of patients and are considered a severe presentation of bipolar I disorder. Further investigation into the potential to manage both depressive and manic symptoms simultaneously with one treatment is warranted.”
Asenapine is a tetracyclic antipsychotic therapy for the treatment of moderate to severe manic episodes associated with bipolar I disorder in adults. The efficacy of asenapine was studied using two scales; for manic symptoms the Young Mania Rating Scale (YMRS) and the Montgomery- Åsberg Depression Rating Scale (MADRS) for depressive symptoms.[1]
The changes in YMRS score from baseline to week 3 were:
Significantly greater with asenapine (-15.0 ± 0.9) compared to placebo (-11.5 ± 1.2; p=0.015)
The difference between olanzapine and placebo was not statistically significant
(-13.3 ± 0.9; p=0.169)
Asenapine was also significantly superior to placebo in change from baseline in MADRS total score at week 3 (-8.2 ± 0.9 versus -4.5 ± 1.2, respectively; p=0.009). The difference between olanzapine and placebo was not statistically significant (-6.5 ± 0.8; p=0.181).[2]
The composite response of both manic and depressive measures (classified as ≥ 50% reduction in YMRS and MADRS scores) rate at week 3 was:
Significantly greater with asenapine (46.3%) than with placebo (24.4%; p=0.023)
The difference between olanzapine and placebo was not statistically significant (37.5%; p=0.141)
The composite remission (YMRS ≤ 12 and MADRS ≤ 10) rate was significantly greater with asenapine (44.8%) than placebo (24.4%; p=0.033) at week 3; the difference with olanzapine was not significant (35.2%; p=0.218).[2]
Bipolar disorder affects 30 million people worldwide including over four million people in Europe.[2] It is the sixth leading cause of disability worldwide.[3] People with bipolar disorder are part of a medically-burdened population that often experience multiple complications. It is estimated that approximately two thirds of patients will suffer a mixed episode at some point in their illness.[4]
Editor notesAbout the post hoc analyses
The efficacy of asenapine in the treatment of mixed episodes was assessed using post hoc analyses on pooled data from two identically designed 3-week, randomised, double blind, flexible dose, placebo- and olanzapine-controlled trials and a 9-week, double-blind olanzapine-controlled extension study.[2]
In the intent-to-treat population, 295 patients has a DSM-IV-TR mixed episode (placebo: 66; olanzapine: 122; asenapine: 107) in the 3-weeks trials. Of these, 102 patients (olanzapine: 56; asenapine: 46) entered the 9-week extension study.[2]
These post hoc analyses were conducted on the pooled 3-week data of the subset of patients diagnosed with a mixed episode according to DSM-IV-TR, and complemented by the data collected during the 9-week extension trial.[2]
About bipolar I disorder
Bipolar disorder (also known as manic-depressive disorder) is a chronic, episodic illness so named because sufferers alternate between two poles of extreme moods – mania and depression.[5] Bipolar I disorder is characterised by mania (episodes of elevated moods, extreme irritability, decreased sleep and increased energy), depression (overwhelming feelings of sadness, suicidal thoughts), or a combination of both.[5]
About asenapine
Asenapine is a sublingual tablet indicated for the treatment of moderate to severe manic episodes of bipolar I disorder in adults. Approximately 4,500 subjects, including more than 3,150 patients in phase II/III studies (including trials in schizophrenia), have contributed to asenapine safety and tolerability data and the clinical trial programme for asenapine has included nearly 1,300 patients with manic or mixed episodes of bipolar I disorder.[6],[7],[8]
About Lundbeck
H. Lundbeck A/S (LUN.CO, LUN DC, HLUKY) is an international pharmaceutical company highly committed to improving the quality of life for people suffering from brain disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at disorders such as depression and anxiety, psychotic disorders, epilepsy and Huntington’s, Alzheimer’s and Parkinson’s diseases.
Lundbeck was founded in 1915 by Hans Lundbeck in Copenhagen, Denmark. Today Lundbeck employs approximately 6,000 people worldwide. Lundbeck is one of the world’s leading pharmaceutical companies working with brain disorders. In 2011, the company’s revenue was DKK 16.0 billion (approximately EUR 2.2 billion or USD 3.0 billion). For more information, please visit http://www.lundbeck.com/.
References
1. Azorin, et al. Remission of Manic and Depressive Symptoms with Asenapine in Patients with Mixed Episodes. Presented at the 25th European College of Neuropsychopharmacology (ECNP) Congress, Vienna, October 2012, Poster 2.e.019
2. World Health Organization. Disease incidence, prevalence and disability. Available at: http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_part3.pdf. Accessed August 24, 2012.
3. Kleinman, L et al. Costs of bipolar disorder. Pharmacoeconomics. 2003;21:601-622.
4. Mackin, P. & Young, A.H. (2005) Bipolar disorders. Core Psychiatry (eds P. Wright, J. Stern, M. Phelan). Edinburgh. Elsevier Saunders.
5. National Institute of Mental Health. Bipolar Disorder 2009. Available at: http://www.nimh.nih.gov/health/publications/bipolar-disorder/nimh-bipolar-adults.pdf. Accessed August 24, 2012.
6. Asenapine Summary of Product Characteristics, 2012.
7. McIntyre, R et al. A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states. Bipolar Disorders. 2009:11:673-686.
8. McIntyre, R et al. Treatment of Mania in Bipolar I Disorder: Placebo and Olanzapine Controlled trials of Asenapine. Congress of European College of Neuropsychopharmacology, October 13-17, 2007, Vienna, Austria.
Source: Lundbeck

element14 drives the Raspberry Pi revolution forward with new “Double Memory” 512MB board

— 512MB boards in stock and available now at element14
— Faster, more rapidly accessible RAM gives the new Raspberry Pi optimal multimedia functionality
— Opens up a whole new world of recreational, educational and commercial applications for Raspberry Pi
LONDON /PRNewswire/ — element14, the first collaborative community and electronics store for design engineers and electronics enthusiasts and a part of global electronics distributor Premier Farnell [LON:PFL], today announced its continued partnership with Raspberry Pi with the launch of a new 512MB board version of the revolutionary, credit-card sized computer. Now with double the RAM, the new higher performance Raspberry Pi 512MB board is suited to multimedia, high-memory and mobile applications. The additional memory is also an enabler to allow the Raspberry Pi to run a future version of an Android 4.0 operating system.
(LOGO: http://photos.prnewswire.com/prnh/20110216/CG49295LOGO)
The 512MB Raspberry Pi board is being manufactured for element14 in the UK by Sony UKTec, as part of the multi-million pound manufacturing deal, which was announced last month. element14 has global stock of the Raspberry Pi 512MB board available now on a first come first served basis through its brands Farnell element14 in Europe, Newark element14 in North America and element14 in Asia Pacific, as well as through subsidiaries CPC in the UK and MCM Electronics in the US.
Mike Buffham, Global Head of EDE for Premier Farnell said: “We have been amazed at just how successful the first generation Raspberry Pi board has been, now the new version will open up even more possibilities. The extra memory also enables higher performance applications and services – there is real potential to do things like add a touchscreen, then a power back and suddenly the Pi becomes mobile.
“We’re really looking forward to seeing what people will do with the new device and would encourage everyone to join our element14 Community which is packed with conversations, debate and knowledge sharing by thousands of enthusiastic developers and first-time programmers keen to get the most from their Raspberry Pi.”
The launch of the first Raspberry Pi board generated worldwide excitement and stimulated an interest in programming and computing from engineers through to school children and teachers.
“The success of the first board has been outstanding and we’ve loved seeing some of the innovative applications and uses that people have been sharing,” said Eben Upton, co-founder of the Raspberry Pi Foundation. “The next generation device opens up new possibilities, and can help open up the vast potential developer community. We’re already seeing people starting to develop their own applications and use the Raspberry Pi in ways we would have never thought possible.”
Costing $35, the same as the previous board, the Raspberry Pi 512MB will initially be sold in one uncased configuration – which has two USB ports, 512MB of RAM, HDMI port, SD memory card slot and an Ethernet port. With 512MB of RAM, the faster, more rapidly accessible memory can be used to create a more effective multimedia performance. It also means that both CPU and GPU both now have sufficient RAM to function optimally. Previously users may have found themselves having to alter the memory allocation CPU / GPU when they needed to swap between playing multimedia and ensuring the CPU still had enough RAM to work efficiently. Having more memory means users can now easily set the memory allocation to a level which means they can use multimedia at will and still have plenty of RAM to run other processes powered by the CPU.
The Raspberry Pi Foundation is a charity formed and supported by influential computing minds and businesses. It believes in the need for more developers to understand what truly goes on ‘under the hood’ of a computing device and is convinced there is a need to rely less on development tools and power hungry layers of code. The element14 Community has been supporting design engineers for over three years and offers organic support, expert advice and information to all members and a platform to share ideas and examples freely.
Members of the element14 Community can join the discussions and share ideas and plans for the Raspberry Pi in the Raspberry Pi Group. Since launch over 7,000 element14 Community members have joined the group from all over the world.
The new Raspberry Pi 512MB board along with a range of exclusive new Raspberry Pi accessories will be demonstrated by element14 at Electronica in Munich from 13-16 November.
About element14
Launched in June 2009, element14 is the first information portal, collaborative community and electronics store specifically built for electronic design engineers. The community recently unveiled its element14 knode, a unique automated platform that enables engineers to quickly research, design, develop and prototype in a single, intelligent environment. element14 is an innovative offering from Premier Farnell plc (LSE:pfl), FTSE 250, a leader in multi-channel electronics distribution trading throughout Europe (Farnell), the Americas (Newark) and Asia Pacific (element14). The company had group sales of £973.1m and underlying profits of £104.6m last year.
About Premier Farnell
Premier Farnell plc (LSE:pfl) is a global leader in high service distribution of technology products and solutions for electronic system design, maintenance and repair. Its differentiated proposition includes 29 local language transactional websites, and the critically important element14 Community for design engineers – an industry first (www.element14.com). With sales last year of £973.1m and underlying profits of £104.6m the Group distributes its comprehensive portfolio of products and services throughout Europe, North America and Asia Pacific, supported by a global supply chain of over 3,500 suppliers and an inventory profile developed to anticipate and meet its customers’ needs.
While global in scope, Premier Farnell recognises the individual needs of each market and has continued to internationalise its model accordingly. It trades locally as Farnell in Europe, Newark/element14 in North America and Mexico and Farnell Newark in Brazil. Across Asia Pacific the business trades as element14.
For news updates from Premier Farnell visit:
Premier Farnell News Centre – http://www.premierfarnell.com/media-centre
Twitter -@element14news; @element14
YouTube –element14
Facebook –/element14page
Email:pressoffice@premierfarnell.com
European Contact:
Jen Cooke
Communications Europe
Tel: +44 7885 715378
E-mail: JCooke@premierfarnell.com
APAC Contact:
Christina Loh
Communications APAC
Tel: + 65 6671 8769
E-mail: cloh@element14.com
Americas Contact:
Janice Fleisher
Communications Americas
Tel: +001 (1) 773 907 5941
E-mail: jfleisher@newark.com
Ken Leitch
Global Head of PR
Premier Farnell
T: +44(0) 207 851 4145
E: KLeitch@premierfarnell.com
Source: element14

7th China Software and Sourcing Summit to Explore New Paths Forward and Find Advantages in New Global Dynamic

Oct. 31 – Nov. 2 Summit to Connect Global Industry Leaders, Entrepreneurs With Dynamic Chinese Outsourcing Market
XI’AN, China /PRNewswire/ — As business opportunities in China have become increasingly relevant to today’s global economy, the 7th China Software & Sourcing Summit offers participants a prime opportunity for access and insight into the dynamic workings of the Chinese outsourcing industry. One of the biggest events of the year organized by Shaanxi Province Government and supported by the China Ministry of Commerce, China Ministry of Industry and Information Technology, the summit will bring together global entrepreneurs, high-level government officials, experts from China’s leading academic and research institutions, and top executives from multi-national companies in the US, Europe, Japan, and Korea. Attendees will be treated to a highly-anticipated lineup of speakers which includes Guenter Krieger, CIO of BMW Brilliance Automotive; Randy Mott, CIO of General Motors, Chris Kaisand, VP of AIG; Simon Lake, Commercial Director of CLS Services; Eliza Kwok, Managing Director of BT China; Michael P. Connors, Chairman & CEO of ISG, Thomas E. Mead CEO of Globalization Today; together with influential officials from the China Ministry of Commerce (MOC) and the China Ministry of Industry and Information Technology (MIIT); and Mr. Ni Guangnan, a senior fellow from the Chinese Academy of Engineering will address this year’s keynote.
Themed “Finding Advantage in a Dynamic Global Market”, this year’s conference will “take the pulse of the outsourcing industry” and explore new paths forward in the wake of the financial crisis. Presentations, breakout sessions, and exhibitions will emphasize several of the hottest themes in technology, including cloud computing and mobile Internet development. Attendees will be able to participate in the world premiere of the Mobile Internet Developer Competition, a global contest series that will launch in Xi’an. Finally, attendees will have the chance to witness a historic event at this year’s summit: the signing of the Xi’an-Shannon Strategic Cooperation Agreement, marking a partnership between two giants in the software park industry, the Xi’an Software Park and the Shannon Software Park in Ireland. Throughout the conference, participants will enjoy the benefits of continual networking opportunities and unparalleled access to new business openings in the Chinese market, and experience firsthand Xi’an’s enormous potential as a global innovator for software outsourcing and R&D.
The Xi’an High-Tech Zone is currently the biggest driver of economic growth in the city of Xi’an. This zone currently hosts leaders in China’s electronic, manufacturing, and biomedical industries, as well as major international companies like Samsung Electric, Schneider, etc. As recently as on September 12th 2012, Samsung Electronics Co. launched a new USD $7 billion manufacturing facility in the Xi’an High-Tech Zone, which marks the company’s biggest investment in China to date. The Xi’an Software Park, located inside of the High-Tech zone and home to 1,090 IT enterprises and over 100,000 employees, is one of the major IT centers in China.
The city of Xi’an itself is at the heart of the recent technology boom in China. While it is the biggest city in northwestern China, it has a remarkably low cost of living; it also has one of the highest percentages of university talent in its population nationwide. Visitors will be able to experience all of Xi’an’s rich offerings for themselves at the conference. From the famed terracotta warriors to the picturesque Datang Furong Dynasty Garden, Xi’an’s many cultural treasures are only a short ride away from the conference hotel.
For more information, visit http://www.xasoftware-summit.com/ or http://serviceoutsourcing2china.com/.
Source: Xi’an Software Park

COSMOPROF ASIA 2012 Turns the Spotlight on Conferences and Events

14-16 November, Hong Kong Convention and Exhibition Centre
HONG KONG /PRNewswire/ — This edition of Cosmoprof Asia turns the spotlight on conferences and events in different beauty sectors to inform and instruct industry insiders. The programme of seminars will cover a wide range of topics and markets.

The Asia Hair Masters Association (AHMA) will organise its annual Summit during Cosmoprof Asia.

The 5th Cosmoprof Asia Spa Conference will feature 11 spa gurus to discuss new spa trends and business implications, with special focus on Spa Operations.

Hong Kong Professional Nailist Union Competition 2012 will be the spotlight event at the main stage of Grand Hall Avenue.
AHMA Summit and Hairstyling Award Final 2012
This year, the Asia Hair Masters Association (AHMA) will organise its annual Summit on 14 and 15 November at Cosmoprof Asia. During the two-day Summit, the Association will be hosting a series of hairstyling-related activities, including the AHMA Hairstyling Award Final, hair shows and seminars. England’s renowned hair master Mark Leeson (nominated for the British Hairdresser of the Year in 2011 & 2012) and Schwarzkopf Professional will take part in the AHMA hair show on 14 November and host hair seminars on 15 November.
Cosmoprof Asia 2012 SPA Conference
Running since 2008, the Cosmoprof Asia Spa Conference featuring a prestigious panel of international spa gurus will discuss new spa trends and business implications, with special focus on Spa Operations — Training, Pricing & Customer Retention.
In the first session on “Spa Trends”, Georgia Lee, Founder of DrGL® will share successful strategies for running a medi-spa in Asia. Kathryn Moore, Director of Operations for MSPA International, will present the wellness trends in spas in the coming 10 years. A panel discussion on “Staff Training” will follow, anchored by Ceri Silk, Regional Area Manager Asia-Pacific of SKEYNDOR, Jeff Mathews, President & COO of Mandara Spa Asia Ltd, Lisa Mak, Managing Director of Bodywize Wellness and Pamela Adkins, Executive Educational Director of Takara International Esthetic College.
The second panel discussion will focus on the elements needed to attract and retain customers. The panel will comprise Derek Barton, Managing Director of Barr + Wray (HK) Ltd, Samantha Arnold, Regional Vice President — Asia, Aromatherapy Associates, Lynsey Hughes, Spa Director of Mandarin Oriental Hotel Group and Sharon Codner, Regional Spa Director (Asia) of the Peninsula Hong Kong.
Both panel discussions will be moderated by Melinda Yon, Senior Academic Staff, Diploma in Wellness, Lifestyle and Spa Management, at the Republic Polytechnic in Singapore.
Focus on China seminars
“International Cosmetic Conference 2012 — Growing your business in China” will give an in-depth analysis of the Chinese cosmetic market, the evolution in sales channels and the needs of consumers. This session is designed to help foreign brands understand the opportunities and challenges of entering the cosmetics market in China, and fostering cooperation between brands and the Chinese beauty industry.
“How to enter the Chinese Cosmetic Market: Analysis of New Regulations and Introduction of Important Regulations” is a must-attend session to learn how to process cosmetic import registration. Attendees will be given an update on the newly released government policies and health/safety regulations.
Industrial and trends seminars
“Discover the Packaging World” is dedicated to cosmetic manufacturers, brand owners and packaging suppliers. Industry experts will address the latest challenges, trends and technologies for cosmetic packaging and design. Topical issues such as sustainable cosmetic development and the economic cost of cosmetic packaging will also be discussed.
Organic Monitor, first-rate provider of global research and consultation, will share its research and observation of the natural and organic products industry during the seminar “Opportunities in the Global Market for Natural & Organic Cosmetics”. The expert analysis and insight provided will assist companies to make important business decisions and plans to achieve growth in the organic beauty sector.
The leading trend forecast agency, Beautystreams, will present “A Season of Faith: Autumn-Winter 2013/14 Trend Forecast”. The seminar will take the audience through key themes of the season, presenting an original view across specific categories: colors, themes, hair, makeup and nail looks, olfactory, skin care, prints, packaging, and visual merchandising. Fueled by a team of global experts, the seminar will also explore the important sociological macrotrends behind each theme.
Grand Hall Avenue
A brand-new initiative for 2012, the “Grand Hall Avenue” is a dedicated area providing a main stage for live events including nail competition, product demonstrations by exhibitors previewing the latest trends and technique in aesthetic, nail art and professional make up etc.
Special highlight will be the Hong Kong Professional Nailist Union Competition 2012. The event will feature contestants from around the world as well as a renowned and experienced international judging panel.
For updated details of the events and enrollment, please visit http://www.cosmoprof-asia.com.
Notes to Editors:
Cosmoprof Asia is organised by Cosmoprof Asia Ltd, a joint venture company between UBM Asia Ltd and BolognaFiere Group.
About UBM Asia (www.ubmasia.com)
Owned by UBM plc listed on the London Stock Exchange, UBM Asia operates in 19 market sectors with headquarters in Hong Kong and subsidiary companies across Asia, including UBM China in Shanghai, Hangzhou, Guangzhou and Beijing. We have over 240 products including trade fairs, conferences, trade publications, B2B/B2C portals and virtual event services. As Asia’s leading exhibition organiser and the biggest commercial organiser in China, India and Malaysia, we stage the leading events of their kind across the region. Our 200 events, 24 publications and 16 vertical portals serve over 1,000,000 quality exhibitors, visitors, conference delegates, advertisers and subscribers from all over the world with high value face-to-face business-matching events, quality and instant market news and industry trends, and round-the-clock online trading networks and sourcing platforms. We have over 1,100 staff in 21 major cities across Asia, stretching from Japan to Turkey.

About BolognaFiere Group (www.bolognafiere.it/)
BolognaFiere Group, a world’s leading trade show organizer in the cosmetics, fashion, architecture and building, art and culture sectors, features in its portfolio more than 80 exhibitions, among domestic and international events. SoGeCos S.p.A., as organizer of Cosmoprof Worldwide Bologna (established 1967), the most important beauty meeting point in the world that will take place in Bologna next March 8-11 2013, has the privilege to work with the beauty industry in the 5 continents and to monitor new emerging markets where there is a demand for cosmetics products. The International platform offered by Cosmoprof, with its events in Hong Kong (established 1996) and Las Vegas (established 2002) is a real warranty of result in the beauty industry all over the world.
MEDIA CONTACT:
ASIA
UBM Asia Ltd
Ms Amy Ng Tel. +852 2516 1659 | amy.ng@ubm.com
Ms Janice Poon Tel. +852 2516 2117 | janice.poon@ubm.com
WORLDWIDE
SOGECOS
Annalisa Beretta Tel. +39 02 454708225 | annalisa.beretta@cosmoprof.it
BOLOGNAFIERE
Isabella Bonvicini Tel. +39 051 282261 | +39 335 7995370 | isabella.bonvicini@bolognafiere.it
Source: UBM Asia

ChanTest Announces Drug Discovery Services Using the Enamine 3D Compound Library

CLEVELAND /PRNewswire/ — ChanTest, the industry leading ion channel Contract Research Organization (CRO) announces today the addition of a 50,000 compound chemical library from Enamine Ltd., a leading provider of screening compounds and chemical building blocks. This compound library (3D Diversity Set) will be available to ChanTest clients effective immediately as a key tool for drug discovery services.
(Logo: http://photos.prnewswire.com/prnh/20120817/CL58977LOGO )
Enamine created this 3D Diversity Set of compounds by selecting from their 1.6 million compound high throughput screening collection (HTS collection) based on the diversity of three dimensional shapes. All compounds in the HTS collection are “drug-like” according to Lipinski Rules, so compounds in the 3D Diversity Set have maximum diversity based on molecular shape and structural/physiochemical features common to known drugs.
Bill Heilman, Business Development Director, at Enamine, said, “We are excited about partnering with ChanTest. Our company and reputation grows among professional screening companies and academic research centers as more research programs screen our compounds in various assays.”
ChanTest offers screening of the Enamine 3D Diversity Set to clients outsourcing drug discovery screening programs to ChanTest. ChanTest has the broadest selection of ion channel assays-and industry-leading expertise to match. Included with each drug discovery service contract, ChanTest scientists work with clients to design meaningful assays and interpret the results in a cost effective manner. In this case, ChanTest and Enamine will partner with clients to convert hits identified from the non-proprietary library to proprietary leads.
Chris Mathes, Ph.D., Chief Commercial Officer at ChanTest commented, “Discovery services at ChanTest lacked a large compound library for high throughput screening. Thanks to the 3D Diversity Set from Enamine, ChanTest can now use its powerful HTS of Ion Channels, GPCRs and Transporters in partnership with pharma and biotech companies to help discover new drugs.”
About ChanTest — The Ion Channel Expert
ChanTest’s mission is to serve the drug discovery and development needs of customers worldwide with high-value solutions for ion channel and GPCR biology. Since its inception in 1998, the CRO has tested compounds for more than 500 global pharmaceutical and biotechnology companies and partners with them to speed the drug development process for the release of better, safer drugs. ChanTest offers integrated ion channel and GPCR services (GLP and non-GLP) and reagents; the company’s library of validated ion channel cell lines and pre-clinical cardiac risk assessment service portfolio are the most comprehensive commercially available today. Because of ChanTest’s seminal role in the nonclinical cardiac safety field, along with the company’s uncompromising commitment to quality, ChanTest has been named the “most trusted and most used fee-for-service provider” for ion channel screening in an independent survey for the past three years. ChanTest is based in Cleveland, Ohio. For more information, e-mail info@chantest.com.
About Enamine
Established in Kiev in 1991, Enamine, Ltd. is a chemical company supplying novel screening compounds to the pharmaceutical, cosmetic, nutritional and agrochemical industries. Enamine’s design and synthesis capabilities allow the Company to add more than 250,000 new organic compounds to its catalogue of screening compounds each year, with 2 million compounds currently available. These compounds can be downloaded from their web site at: http://www.enamine.net. The Company offers collaborative expertise to exclusively design and supply libraries of new, potentially bioactive organic compounds and building blocks, in addition to furnishing in-house chemical libraries to screening centers worldwide.
Contact:
Chris Mathes, Ph.D.
Chief Commercial Officer
ChanTest Corporation
1-216-584-0522
cmathes@chantest.com
Source: ChanTest Corporation